SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $65,887 | -34.3% | 68,632 | -48.7% | 0.00% | – |
| Q1 2023 | $100,346 | +92.8% | 133,795 | -5.2% | 0.00% | – |
| Q4 2022 | $52,035 | -13.3% | 141,207 | +1.1% | 0.00% | – |
| Q3 2022 | $60,000 | -7.7% | 139,607 | +66.9% | 0.00% | – |
| Q2 2022 | $65,000 | -35.6% | 83,661 | +6.7% | 0.00% | – |
| Q1 2022 | $101,000 | +98.0% | 78,418 | +94.0% | 0.00% | – |
| Q4 2021 | $51,000 | -65.3% | 40,418 | -39.9% | 0.00% | – |
| Q3 2021 | $147,000 | +47.0% | 67,262 | +152.8% | 0.00% | – |
| Q2 2021 | $100,000 | -22.5% | 26,605 | -32.7% | 0.00% | – |
| Q1 2021 | $129,000 | +1190.0% | 39,514 | +1217.6% | 0.00% | – |
| Q4 2020 | $10,000 | -52.4% | 2,999 | -41.1% | 0.00% | – |
| Q3 2020 | $21,000 | -79.6% | 5,095 | -83.3% | 0.00% | – |
| Q2 2020 | $103,000 | +586.7% | 30,536 | +370.9% | 0.00% | – |
| Q1 2020 | $15,000 | -97.5% | 6,484 | -96.0% | 0.00% | -100.0% |
| Q4 2019 | $590,000 | +217.2% | 162,146 | +624.4% | 0.00% | +100.0% |
| Q3 2019 | $186,000 | +313.3% | 22,382 | +331.1% | 0.00% | – |
| Q4 2018 | $45,000 | -86.0% | 5,192 | -72.8% | 0.00% | -100.0% |
| Q3 2018 | $321,000 | +43.9% | 19,106 | +79.8% | 0.00% | +50.0% |
| Q2 2018 | $223,000 | +291.2% | 10,624 | +201.3% | 0.00% | +100.0% |
| Q1 2018 | $57,000 | -31.3% | 3,526 | -19.4% | 0.00% | 0.0% |
| Q4 2017 | $83,000 | +80.4% | 4,375 | -38.7% | 0.00% | 0.0% |
| Q1 2017 | $46,000 | -17.9% | 7,138 | -43.3% | 0.00% | 0.0% |
| Q4 2016 | $56,000 | -5.1% | 12,580 | +0.4% | 0.00% | 0.0% |
| Q3 2016 | $59,000 | -16.9% | 12,533 | +16.7% | 0.00% | 0.0% |
| Q2 2016 | $71,000 | -21.1% | 10,737 | -28.8% | 0.00% | 0.0% |
| Q3 2015 | $90,000 | -61.4% | 15,072 | -60.7% | 0.00% | -75.0% |
| Q1 2015 | $233,000 | -13.4% | 38,386 | -1.1% | 0.00% | 0.0% |
| Q4 2014 | $269,000 | +13.0% | 38,808 | +33.0% | 0.00% | 0.0% |
| Q3 2014 | $238,000 | +67.6% | 29,187 | +67.4% | 0.00% | +100.0% |
| Q2 2014 | $142,000 | -8.4% | 17,435 | -11.8% | 0.00% | -33.3% |
| Q1 2014 | $155,000 | -21.3% | 19,764 | -11.2% | 0.00% | 0.0% |
| Q4 2013 | $197,000 | -32.3% | 22,256 | -42.9% | 0.00% | -57.1% |
| Q2 2013 | $291,000 | – | 38,955 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |